NFKB1 and atherosclerosis: A decrease in the gene expression of NF-κB has been observed in aortas of SHR treated with the AT1R blocker, candesartan [59], and inactivation of NF-κB has been found in aortas of rats infused with ANGII and then treated with losartan [60]; in macrophages and vascular smooth muscle cells from a rabbit model of atherosclerosis after the treatment with quinapril [19]; in the kidney cortex of rats with unilateral urethral obstruction treated with enalapril [61], and in captopril-treated uveitis [29].